Not logged in Understanding tumor-immune-stromal dynamics driving response and resistance to immune checkpoint blockade in melanoma Tarantino, Giuseppe; He, Yiwen; Solanky, Priyanka; Cui, Xinyu; Pfaff, Kathleen; Thorner, Aaron R.; Blosser, Timothy; Boblitt, Elliot; Frangieh, Allison; Aprati, Tyler; Zhang, Boyang; Chen, Jiajia; Faulkner, Hannah Mae; Lawless, Aleigha; Manos, Michael; Helvie, Karla; Sharova, Tatyana; Frederick, Dennie; Krishna, Sachi; Mangum, Chanell; Abbondanza, Domenic; Mccann, Cai; Johnson, Bruce; Shalek, Alex K.; Van Allen, Eliezer; Zhuang, Xiaowei; Sullivan, Ryan; Engelhardt, Barbara; Farhi, Sami; Rodig, Scott; Hodi, F. Stephen; Boland, Genevieve M.; Liu, David Share Save
Share Save
Rationale and feasibility of a rapid integral biomarker program that informs immune-oncology clinical trials: the ADVISE trial Luke, Jason J.; Bever, Katherine; Hodi, F. Stephen; Taube, Janis; Massey, Ashish; Yao, David; Neely, Jaclyn; Tam, Rachel; Lee, George; Gupta, Akshita; Dutta, Santanu; Szabo, Peter; Bao, Riyue; Reilly, Tim Share Save
Share Save
Cigarette Smoking and Symptom Burden: Baseline Results From Nine ECOG-ACRIN Cancer Clinical Trials Price, Sarah N.; Lee, Ju-Whei; Gareen, Ilana F.; Kircher, Sheetal M.; Kumar, Shaji K.; Mayer, Ingrid A.; Saba, Nabil F.; Fenske, Timothy S.; Atkins, Michael B.; Hodi, F. Stephen; Kyriakopoulos, Christos E.; Tempany-Afdhal, Clare M.; Shanafelt, Tait D.; Park, Elyse R.; Wagner, Lynne I. Share Save
Share Save
Nivolumab plus relatlimab vs nivolumab in previously untreated metastatic or unresectable melanoma: 3-year subgroup analyses from RELATIVITY-047 Schadendorf, D.; Tawbi, H. A.; Hodi, F. S.; Lipson, E. J.; Ascierto, P. A.; Medina Soto, F. A.; Maio, M.; Hernberg, M.; Mackiewicz, J.; Prey, S.; Mujika Eizmendi, M. K.; Atkinson, V. G.; Hassel, J. C.; Cinat, G.; Keidel, S.; Rodriguez, S.; Wang, P. T.; Dolfi, S.; Long, G. V. Share Save
10-y survival outcomes from the phase III CheckMate 067 trial of nivolumab plus ipilimumab in advanced melanoma Larkin, J.; Sileni, V. Chiarion; Marqueste, C. Gaudy; Rutkowski, P.; Medina, T. M.; Lao, C. D.; Cowey, C. L.; Schadendorf, D.; Wagstaff, J.; Dummer, R.; Queirolo, P.; Walker, J.; Butler, M. O.; Hill, A. G.; Marquez-Rodas, I.; Haanen, J. B. A. G.; Nassar, A.; Askelson, M.; Hodi, F. S.; Wolchok, J. D. Share Save
Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer Tsimberidou, Apostolia M.; Alayli, Farah A.; Okrah, Kwame; Drakaki, Alexandra; Khalil, Danny N.; Kummar, Shivaani; Khan, Saad A.; Hodi, F. Stephen; Oh, David Y.; Cabanski, Christopher R.; Gautam, Shikha; Meier, Stefanie L.; Amouzgar, Meelad; Pfeiffer, Shannon M.; Kageyama, Robin; Yang, Enjun; Spasic, Marko; Tetzlaff, Michael T.; Foo, Wai Chin; Hollmann, Travis J.; Li, Yanyun; Adamow, Matthew; Wong, Phillip; Moore, Jonni S.; Velichko, Sharlene; Chen, Richard O.; Kumar, Dinesh; Bucktrout, Samantha; Ibrahim, Ramy; Dugan, Ute; Salvador, Lisa; Hubbard-Lucey, Vanessa M.; O'Donnell-Tormey, Jill; Santulli-Marotto, Sandra; Butterfield, Lisa H.; Da Silva, Diane M.; Fairchild, Justin; Lavallee, Theresa M.; Padron, Lacey J.; Sharma, Padmanee Share Save
Share Save
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors: Findings from a phase 1/1b study Baranda, Joaquina C.; Robbrecht, Debbie; Sullivan, Ryan; Doger, Bernard; Santoro, Armando; Barve, Minal; Grob, Jean-Jacques; Bechter, Oliver; Vieito, Maria; de Miguel, Maria Jose; Schadendorf, Dirk; Johnson, Melissa; Pouzin, Clemence; Cantalloube, Cathy; Wang, Rui; Lee, Jooyun; Chen, Xiaofei; Demers, Brigitte; Amrate, Amele; Abbadessa, Giovanni; Hodi, F. Stephen Share Save
Transmural Flow Upregulates PD-L1 Expression in Microvascular Networks Wan, Zhengpeng; Zhang, Shun; Zhong, Amy X.; Xu, Liling; Coughlin, Mark F.; Pavlou, Georgios; Shelton, Sarah E.; Nguyen, Huu Tuan; Hirose, Satomi; Kim, Seunggyu; Floryan, Marie A.; Barbie, David A.; Hodi, F. Stephen; Kamm, Roger D. Share Save
Immune profiling for improving responsiveness to ipilimumab plus nivolumab checkpoint blockade treatment in patients with metastatic melanoma Baginska, Joanna; Chen, Jiajia; Tarantino, Giuseppe; Giobbie-Hurder, Anita; Weirather, Jason L.; Severgnini, Mariano; Manos, Michael; Burke, Kelly; Russell, Janice D.; Brainard, Martha; Gabriel, Elizabeth; Brennick, Ryan; Nazzaro, Matthew; Hathaway, Emma; Holovatska, Marta; Manuszak, Claire; Ranashinge, Srinika; Liu, David; Hodi, F. Stephen Share Save
Liquid biopsy epigenomic profiling for cancer subtyping (vol 29, pg 2737, 2023) Baca, Sylvan C.; Seo, Ji-Heui; Davidsohn, Matthew P.; Fortunato, Brad; Semaan, Karl; Sotudian, Shahabbedin; Lakshminarayanan, Gitanjali; Diossy, Miklos; Qiu, Xintao; El Zarif, Talal; Savignano, Hunter; Canniff, John; Madueke, Ikenna; Saliby, Renee Maria; Zhang, Ziwei; Li, Rong; Jiang, Yijia; Taing, Len; Awad, Mark; Chau, Cindy H.; Decaprio, James A.; Figg, William D.; Greten, Tim F.; Hata, Aaron N.; Hodi, F. Stephen; Hughes, Melissa E.; Ligon, Keith L.; Lin, Nancy; Ng, Kimmie; Oser, Matthew G.; Meador, Catherine; Parsons, Heather A.; Pomerantz, Mark M.; Rajan, Arun; Ritz, Jerome; Thakuria, Manisha; Tolaney, Sara M.; Wen, Patrick Y.; Long, Henry; Berchuck, Jacob E.; Szallasi, Zoltan; Choueiri, Toni K.; Freedman, Matthew L. Share Save
Liquid biopsy epigenomic profiling for cancer subtyping Baca, Sylvan C.; Seo, Ji-Heui; Davidsohn, Matthew P.; Fortunato, Brad; Semaan, Karl; Sotudian, Shahabbedin; Lakshminarayanan, Gitanjali; Diossy, Miklos; Qiu, Xintao; El Zarif, Talal; Savignano, Hunter; Canniff, John; Madueke, Ikenna; Saliby, Renee Maria; Zhang, Ziwei; Li, Rong; Jiang, Yijia; Taing, Len; Awad, Mark; Chau, Cindy H.; Decaprio, James A.; Figg, William D.; Greten, Tim F.; Hata, Aaron N.; Hodi, F. Stephen; Hughes, Melissa E.; Ligon, Keith L.; Lin, Nancy; Ng, Kimmie; Oser, Matthew G.; Meador, Catherine; Parsons, Heather A.; Pomerantz, Mark M.; Rajan, Arun; Ritz, Jerome; Thakuria, Manisha; Tolaney, Sara M.; Wen, Patrick Y.; Long, Henry; Berchuck, Jacob E.; Szallasi, Zoltan; Choueiri, Toni K.; Freedman, Matthew L. Share Save
Unraveling relatlimab (RELA)-specific biology using biomarker analyses in patients with advanced melanoma treated with nivolumab (NIVO) plus RELA or NIVO alone in RELATIVITY-047 Lipson, E. J.; Dolfi, S.; Tang, H.; Gogas, H.; Tawbi, H. A.; Hodi, F. S.; Ascierto, P. A.; Gutierrez, E. C.; Schadendorf, D.; Soto, F. A. Medina; Rutkowski, P.; Ramirez, E. Murillo; Maio, M.; Xu, Y.; Desai, K.; Yu, A.; Demers, K.; Miller-Moslin, K.; Long, G. V.; Garnett-Benson, C. Share Save
Comparison of intracranial (IC) response assessment criteria in patients (pts) with melanoma brain metastases (MBM) treated with combination nivolumab (NIVO) plus ipilimumab (IPI) in CheckMate 204 Huang, R.; Youssef, G.; Nelson, T.; Wen, P.; Forsyth, P.; Hodi, F. S.; Margolin, K. A.; Algazi, A. P.; Hamid, O.; Lao, C. D.; Ernstoff, M. S.; Moschos, S. J.; Atkins, M. B.; Postow, M.; Reardon, D. A.; Grootendorst, D. J.; Askelson, M.; Ritchings, C.; Tawbi, H. A. Share Save
Nivolumab (NIVO) plus relatlimab (RELA) vs NIVO in previously untreated metastatic or unresectable melanoma: 2-year subgroup analyses from RELATIVITY-047 Long, G. V.; Hodi, F. S.; Lipson, E. J.; Schadendorf, D.; Ascierto, P. A.; Soto, F. A. Medina; Maio, M.; Hernberg, M.; Mackiewicz, J.; Prey, S.; Eizmendi, M. K. Mujika; Atkinson, V. G.; Hassel, J. C.; Cinat, G.; Ratto, B.; Rodriguez, S.; Wang, P. T.; Dolfi, S.; Tawbi, H. A. Share Save
Share Save
Profiling of Natural Killer Interactions With Cancer Cells Using Mass Cytometry Hallisey, Margaret; Dennis, Jenna; Gabriel, Elizabeth P.; Masciarelli, Alyssa; Chen, Jiajia; Abrecht, Charlotte; Brainard, Martha; Marcotte, William M.; Dong, Han; Hathaway, Emma; Tarannum, Mubin; Vergara, Juliana A.; Schork, Abigail N.; Tyan, Kevin; Tarantino, Giuseppe; Liu, David; Romee, Rizwan; Rahma, Osama E.; Severgnini, Mariano; Hodi, Stephen; Baginska, Joanna Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
